ScriptDrop and Louvir partner to improve access to medicines

ScriptDrop, Inc., a health technology company dedicated to national prescription access, and Louvir, a data aggregation platform focused on uncovering savings opportunities for 340B patients, announce their collaboration. This aims to optimize access to medicines by integrating the delivery of prescriptions. This partnership aims to enable same-day or next-day delivery of medications via the Louvir platform.

Louvir facilitates the management, compliance and expansion of 340B programs through continuous analysis of data from various systems. ScriptDrop offers an integrated prescription delivery solution, making it easier to get medications to patients. The union of these two platforms promises to accelerate the accessibility of medicines for at-risk populations and generate additional revenue for covered entities through the delivery of prescriptions. This collaboration will be integrated into a new solution called Louvir Link, scheduled to be launched soon.

Amanda Epp, CEO of ScriptDrop, and Brad Becker, CEO of Louvir, both expressed enthusiasm for this joint initiative, highlighting the shared goal of improving medication accessibility for disadvantaged populations in the United States. They are banking on this collaboration to strengthen treatment adherence and health outcomes by overcoming obstacles such as transportation challenges and pharmaceutical deserts.